Global Information
회사소개 | 문의 | 비교리스트

세계의 안과용 의약품 시장 : 항녹내장약, 건성안 치료제, 기타(망막 장애, 항감염제/알레르기)

Ophthalmology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

리서치사 The Business Research Company
발행일 2020년 05월 상품 코드 531334
페이지 정보 영문
가격
US $ 4,000 ₩ 5,010,000 PDF by E-mail (Single User License)
US $ 6,000 ₩ 7,515,000 PDF by E-mail (Site License)
US $ 8,000 ₩ 10,020,000 PDF by E-mail (Enterprise License)


세계의 안과용 의약품 시장 : 항녹내장약, 건성안 치료제, 기타(망막 장애, 항감염제/알레르기) Ophthalmology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
발행일 : 2020년 05월 페이지 정보 : 영문

세계의 안과용 의약품 시장을 조사했으며, 시장 정의와 개요, 시장에 대한 각종 영향요인 분석, 약제 부문·지역·국가별 동향과 시장 규모 추이 및 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 안과용 의약품 시장 분석 : 세분화별

  • 세계 시장의 실적 : 부문별
    • 항녹내장약
    • 건성안 치료제
    • 기타
      • 망막 장애
      • 항감염제/알레르기
  • 세계 시장의 추이와 예측 : 부문별
  • 시장 동향·전략

제6장 안과용 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 부문·지역별
  • 세계 의약품 시장의 실적 : 부문·국가별

제7장 거시경제 요인과 시장의 비교

  • 시장 규모의 GDP에서 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장의 비교 : 국가별

  • 시장 규모의 GDP에서 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장의 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품회사 수 : 국가별
  • 시장 매출 vs 의약품회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 매출 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 매출 비율 : 국가별
  • 녹내장 환자 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제17장 경쟁 환경

  • 기업 개요
  • Novartis Ag
  • Regeneron
  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.

제18장 주요 M&A : 안과용 의약품 시장

제19장 시장 배경 : 의약품 시장

제20장 의약품 산업의 파이낸셜 마진

제21장 부록

KSA 17.08.07

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

‘Ophthalmology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Ophthalmology Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider ophthalmology drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, ophthalmology drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Novartis AG; F. Hoffmann-La Roche Ltd; Allergan Plc; Valeant Pharmaceuticals Intl Inc; Bayer AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, ophthalmology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Ophthalmology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Ophthalmology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Ophthalmology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Ophthalmology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Ophthalmology Drugs Market Trends And Strategies

8. Ophthalmology Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Ophthalmology Drugs Market Regional Analysis

  • 9.1. Global Ophthalmology Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region

10. Ophthalmology Drugs Market Segmentation

  • 10.1. Global Ophthalmology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Antiglaucoma Drugs

Dry Eye Medication

Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

  • 10.2. Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Ophthalmology Drugs Market Metrics

  • 11.1. Ophthalmology Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Ophthalmology Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Ophthalmology Drugs Market

  • 12.1. Asia-Pacific Ophthalmology Drugs Market Overview
  • 12.2. Asia-Pacific, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Ophthalmology Drugs Market Metrics
    • 12.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • 12.6. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
    • 12.7.1. China Ophthalmology Drugs Market
      • 12.7.1.1. China Ophthalmology Drugs Market Overview
      • 12.7.1.2. China Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Ophthalmology Drugs Market
      • 12.7.2.1. Australia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Ophthalmology Drugs Market
      • 12.7.3.1. Hong Kong Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Ophthalmology Drugs Market
      • 12.7.4.1. India Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Ophthalmology Drugs Market
      • 12.7.5.1. Indonesia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Ophthalmology Drugs Market
      • 12.7.6.1. Japan Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Ophthalmology Drugs Market
      • 12.7.7.1. Malaysia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Ophthalmology Drugs Market
      • 12.7.8.1. New Zealand Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Ophthalmology Drugs Market
      • 12.7.9.1. Philippines Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Ophthalmology Drugs Market
      • 12.7.10.1. Singapore Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Ophthalmology Drugs Market
      • 12.7.11.1. South Korea Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Ophthalmology Drugs Market
      • 12.7.12.1. Thailand Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Ophthalmology Drugs Market
      • 12.7.13.1. Vietnam Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Ophthalmology Drugs Market

  • 13.1. Western Europe Ophthalmology Drugs Market Overview
  • 13.2. Western Europe, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Ophthalmology Drugs Market Metrics
    • 13.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Western Europe Countries
  • 13.6. Western Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Ophthalmology Drugs Market: Country Analysis
    • 13.7.1. Austria Ophthalmology Drugs Market
      • 13.7.1.1. Austria Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Ophthalmology Drugs Market
      • 13.7.2.1. Belgium Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Ophthalmology Drugs Market
      • 13.7.3.1. Denmark Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Ophthalmology Drugs Market
      • 13.7.4.1. Finland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Ophthalmology Drugs Market
      • 13.7.5.1. France Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Ophthalmology Drugs Market
      • 13.7.6.1. Germany Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Ophthalmology Drugs Market
      • 13.7.7.1. Ireland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Ophthalmology Drugs Market
      • 13.7.8.1. Italy Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Ophthalmology Drugs Market
      • 13.7.9.1. Netherlands Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Ophthalmology Drugs Market
      • 13.7.10.1. Norway Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Ophthalmology Drugs Market
      • 13.7.11.1. Portugal Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Ophthalmology Drugs Market
      • 13.7.12.1. Spain Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Ophthalmology Drugs Market
      • 13.7.13.1. Sweden Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Ophthalmology Drugs Market
      • 13.7.14.1. Switzerland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Ophthalmology Drugs Market
      • 13.7.15.1. UK Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Ophthalmology Drugs Market

  • 14.1. Eastern Europe Ophthalmology Drugs Market Overview
  • 14.2. Eastern Europe, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Ophthalmology Drugs Market Metrics
    • 14.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • 14.6. Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Ophthalmology Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Ophthalmology Drugs Market,
      • 14.7.1.1. Czech Republic Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Ophthalmology Drugs Market
      • 14.7.2.1. Poland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Ophthalmology Drugs Market
      • 14.7.3.1. Romania Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Ophthalmology Drugs Market
      • 14.7.4.1. Russia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Ophthalmology Drugs Market

  • 15.1. North America Ophthalmology Drugs Market Overview
  • 15.2. North America, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Ophthalmology Drugs Market Metrics
    • 15.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, North America Countries
  • 15.6. North America Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Ophthalmology Drugs Market: Country Analysis
    • 15.7.1. Canada Ophthalmology Drugs Market
      • 15.7.1.1. Canada Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Ophthalmology Drugs Market
      • 15.7.2.1. Mexico Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Ophthalmology Drugs Market
      • 15.7.3.1. USA Ophthalmology Drugs Market Overview
      • 15.7.3.2. USA Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Ophthalmology Drugs Market

  • 16.1. South America Ophthalmology Drugs Market Overview
  • 16.2. South America, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Ophthalmology Drugs Market Metrics
    • 16.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, South America Countries
  • 16.6. South America Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Ophthalmology Drugs Market: Country Analysis
    • 16.7.1. Argentina Ophthalmology Drugs Market
      • 16.7.1.1. Argentina Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Ophthalmology Drugs Market
      • 16.7.1.1. Brazil Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Ophthalmology Drugs Market
      • 16.7.3.1. Chile Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Ophthalmology Drugs Market
      • 16.7.4.1. Colombia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Ophthalmology Drugs Market
      • 16.7.5.1. Peru Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Ophthalmology Drugs Market
      • 16.7.6.1. Venezuela Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Ophthalmology Drugs Market

  • 17.1. Middle East Ophthalmology Drugs Market Overview
  • 17.2. Middle East, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Ophthalmology Drugs Market Metrics
    • 17.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Middle East Countries
  • 17.6. Middle East Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Ophthalmology Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Ophthalmology Drugs Market
      • 17.7.1.1. Saudi Arabia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Ophthalmology Drugs Market
      • 17.7.2.1. Israel Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Ophthalmology Drugs Market
      • 17.7.3.1. Turkey Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Ophthalmology Drugs Market
      • 17.7.4.1. UAE Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Ophthalmology Drugs Market

  • 18.1. Africa Ophthalmology Drugs Market Overview
  • 18.2. Africa, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Ophthalmology Drugs Market Metrics
    • 18.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Africa Countries
  • 18.6. Africa Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Ophthalmology Drugs Market: Country Analysis
    • 18.7.1. Egypt Ophthalmology Drugs Market
      • 18.7.1.1. Egypt Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Ophthalmology Drugs Market
      • 18.7.2.1. Nigeria Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Ophthalmology Drugs Market
      • 18.7.3.1. South Africa Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Ophthalmology Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Novartis AG
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. F. Hoffmann-La Roche Ltd
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Allergan Plc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Valeant Pharmaceuticals Intl Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Bayer AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Ophthalmology Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Ophthalmology Drugs Market In 2023- Growth Countries
  • 22.2. Global Ophthalmology Drugs Market In 2023- Growth Segments
  • 22.3. Global Ophthalmology Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top
전화 문의
F A Q